Total Equity - Adaptimmune Therapeutics PLC (NASDAQ:ADAP) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 1.02 USD -0.97%

Updated:

Adaptimmune Therapeutics PLC
Total Equity

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

|

Adjust for Inflation

Adaptimmune Therapeutics PLC
Total Equity Peer Comparison

CNTA

AUTL

BCYC

IMCR

GNS

Company		Total Equity	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Adaptimmune Therapeutics PLC NASDAQ:ADAP	Total Equity $24.4m	CAGR 3-Years -57%	CAGR 5-Years -36%	CAGR 10-Years N/A
	Centessa Pharmaceuticals PLC NASDAQ:CNTA	Total Equity $236.2m	CAGR 3-Years 324%	CAGR 5-Years N/A	CAGR 10-Years N/A
	Autolus Therapeutics PLC NASDAQ:AUTL	Total Equity $111.5m	CAGR 3-Years -19%	CAGR 5-Years N/A	CAGR 10-Years N/A
	Bicycle Therapeutics PLC NASDAQ:BCYC	Total Equity $356m	CAGR 3-Years 36%	CAGR 5-Years 49%	CAGR 10-Years N/A
	Immunocore Holdings PLC NASDAQ:IMCR	Total Equity £368.8m	CAGR 3-Years 88%	CAGR 5-Years 45%	CAGR 10-Years N/A
	Genus PLC LSE:GNS	Total Equity £574.8m	CAGR 3-Years 5%	CAGR 5-Years 3%	CAGR 10-Years 7%

See Also

Based on the financial report for Mar 31, 2024, Adaptimmune Therapeutics PLC's Total Equity amounts to 24.4m USD.

Over the last year, the Total Equity growth was -71%. The average annual Total Equity growth rates for Adaptimmune Therapeutics PLC have been -57% over the past three years , -36% over the past five years .

Join more than 145,700+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.